4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0002044770-26-000002
Director acquired 2,233 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Goodrich Katherine Director | 2025-12-15 | Option exercise | +2,233 | 2,233 | D | ||
| Derivatives | |||||||
| Goodrich Katherine Director | 2025-12-15 | Option exercise · Restricted Stock Units | −2,233 | 4,467 | D | ||
Loading xslF345X05/wk-form4_1768437158.xml…